Study guide

4.3 Acute Anaphylaxis, Hypoglycaemia & Seizure Emergencies

RCSI FNM Overseas Aptitude Test NMBI Registration

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Assessment Framework

1.1 Structure of the Overseas Aptitude Test 1.2 NMBI Registration Standards & the Irish Healthcare System 1.3 Preparation, the Official Reading List & OSCE Strategy

2 The Nursing Process & Fundamentals of Care

2.1 The Nursing Process (ADPIE) in the Acute Situation 2.2 Fundamentals of Nursing Care & Activities of Daily Living

3 Systematic Assessment & Physiological Monitoring

3.1 The ABCDE Systematic Assessment Approach in Irish Practice 3.2 Vital Signs: Measurement Technique, Pulse Oximetry & Blood Pressure 3.3 Irish National Early Warning System (INEWS Version 2) Protocol 3.4 Neurological Assessment: GCS, ACVPU & Acute Deterioration

4 Acute Deterioration, Sepsis & Resuscitation

4.1 Sepsis Recognition, NCG No. 26 & the Sepsis 6 Bundle 4.2 Basic Life Support (BLS) & In-Hospital Cardiac Arrest 4.3 Acute Anaphylaxis, Hypoglycaemia & Seizure Emergencies

5 Perioperative & Procedural Nursing Care

5.1 Preoperative Preparation, Fasting & WHO Surgical Checklist 5.2 Postoperative Recovery, PACU Handover & Complications 5.3 Pain Assessment, Multimodal Analgesia & Epidural/PCA Care

6 Wound Management, Tissue Viability & Skin Integrity

6.1 Wound Assessment, Healing Physiology & the TIME Framework 6.2 Aseptic Non-Touch Technique (ANTT) & Wound Dressing Selection 6.3 Pressure Injury Prevention, Staging & the Waterlow Scale

7 Essential Clinical Skills & Invasive Devices

7.1 Enteral Nutrition, Nasogastric Tube Placement & Safety 7.2 Urinary Catheterisation: Aseptic Insertion & CAUTI Prevention 7.3 Stoma Care, Tracheostomy Management & Oxygen Delivery 7.4 Peripheral Venous Catheters, IV Therapy & the PVC Care Bundle

8 Cardiovascular Pathophysiology & Nursing Management

8.1 Acute Coronary Syndromes (ACS) & Heart Failure 8.2 ECG Rhythm Interpretation, Arrhythmias & Nursing Interventions 8.3 Hypertension, Venous Thromboembolism (VTE) & Anticoagulation 8.4 Stroke and TIA: FAST Recognition, Acute Care & Rehabilitation

9 Respiratory & Endocrine Pathophysiology

9.1 Chronic Obstructive Pulmonary Disease (COPD), Asthma & Pneumonia 9.2 Respiratory Investigations, Inhaler and Nebuliser Technique & the MRC Dyspnoea Scale 9.3 Arterial Blood Gas (ABG) Interpretation & Acid-Base Disturbances 9.4 Diabetes Mellitus: Type 1, Type 2, DKA & HHS Management

10 Gastrointestinal Care & Bowel Health

10.1 Constipation, Bowel Assessment & the Bristol Stool Chart 10.2 Upper GI Disorders: H. pylori, Peptic Ulcer, Gastroscopy & Coffee-Ground Vomiting

11 Nutrition, Weight & Health Promotion

11.1 Malnutrition Screening with MUST, Nutritional Support & the Food Pyramid 11.2 Obesity, Osteoporosis, Bone Health & Social Prescribing

12 Fluid, Electrolyte & Renal Homeostasis

12.1 Fluid Balance, Dehydration, Overload & Intake/Output Monitoring 12.2 Electrolyte Imbalances: Potassium, Sodium, Calcium & Magnesium 12.3 Acute Kidney Injury (AKI), Chronic Kidney Disease & Management 12.4 Urinalysis Interpretation & Urine Specimen Collection

13 Pharmacology, Medication Safety & Calculations

13.1 Pharmacokinetics, Pharmacodynamics & High-Alert Medications 13.2 NMBI Medication Management Guidance & Controlled Drug Regulations 13.3 Drug Calculations, Metric Conversions & IV Infusion Flow Rates 13.4 Medication Safety, Vaccination, Antimicrobial Stewardship & Time-Critical Medicines

14 Care of the Older Person

14.1 Delirium Recognition, the 4AT & Acute Confusion 14.2 Dementia Care and the Irish National Dementia Strategy 14.3 Frailty, the Clinical Frailty Scale & Frailty Intervention Teams 14.4 Deconditioning, Get Up Get Dressed Get Moving & Discharge Planning

15 Palliative & End-of-Life Care

15.1 Palliative Symptom Management, Constipation (NCG No. 10) & Syringe Drivers 15.2 End-of-Life Care, the End-of-Life Symbol & Care After the Patient Dies

16 Professional Values, Ethics & Irish Healthcare Law

16.1 The NMBI Code of Professional Conduct and Ethics: Five Principles 16.2 Assisted Decision-Making (Capacity) Act 2015 & Informed Consent 16.3 NMBI Scope of Nursing and Midwifery Practice Framework 16.4 Confidentiality, GDPR, Adult Safeguarding & Open Disclosure 16.5 Irish Health Policy: Healthy Ireland, HIQA Standards, Your Service Your Say & Community Care

17 Management, Patient Safety & Infection Control

17.1 Infection Prevention & Control: Standard & Transmission-Based Precautions 17.2 Hand Hygiene (WHO 5 Moments), Sharps Safety & Waste Segregation 17.3 Delegation, Prioritisation, Workload & Incident Reporting 17.4 Falls Risk Assessment (STRATIFY), Ergonomics & Manual Handling

18 Clinical Communication & Interpersonal Collaboration

18.1 Structured Handover Using ISBAR: Communication & Pitfalls 18.2 Person-Centred Communication, Active Listening & Conflict Resolution 18.3 Breaking Bad News, End-of-Life Communication & Difficult Conversations 18.4 Culturally Congruent Care, Interpreter Use & Health Literacy

19 Leadership, Evidence-Based Practice & Scholarship

19.1 Evidence-Based Nursing & Translating Research to Practice 19.2 Clinical Audit, Quality Improvement & Key Performance Indicators 19.3 Reflective Practice (Gibbs, Johns), Continuing Professional Development 19.4 Teaching the Junior Student Nurse & the Quality Clinical Learning Environment

4.3 Acute Anaphylaxis, Hypoglycaemia & Seizure Emergencies

Key Takeaways Explain This Topic AI

Anaphylaxis is a severe, life-threatening systemic hypersensitivity reaction requiring immediate first-line Intramuscular (IM) Adrenaline (Epinephrine) 1:1,000 at a dose of 0.5 mg (0.5 mL) into the anterolateral mid-thigh, repeated every 5 minutes as needed.

Patients in anaphylaxis must be positioned flat with legs elevated to preserve venous return (or seated upright if airway/dyspnoea is predominant); standing or walking must be strictly forbidden due to the risk of fatal empty vena cava syndrome.

Hypoglycaemia in Irish hospital practice is defined as blood glucose <4.0 mmol/L ("Rule of 15"), managed in conscious patients with 15-20g fast-acting carbohydrate, re-tested after 15 minutes, and followed by complex carbohydrate once normalized.

Severe hypoglycaemia in unconscious or dysphagic patients requires 100-150 mL of IV 10% Glucose over 10-15 minutes or 1 mg IM Glucagon if venous access is unavailable.

Generalized tonic-clonic seizures lasting >5 minutes constitute status epilepticus, requiring protection from injury, high-flow oxygen, airway maintenance in the recovery position once jerking stops, blood glucose verification, and prescribed emergency benzodiazepine administration (e.g. IV lorazepam or buccal midazolam).

Last updated: September 2026

Acute Anaphylaxis, Hypoglycaemia & Seizure Emergencies

Core Clinical Mandate: Medical emergencies on acute hospital wards develop rapidly and require decisive, evidence-based nursing interventions. Whether encountering sudden systemic anaphylaxis following medication administration, neuroglycopenic collapse from severe hypoglycaemia, or status epilepticus, the registered nurse must prioritize the ABCDE sequence, administer time-critical pharmacotherapy, and maintain patient safety.

1. Acute Anaphylaxis: Recognition & Management

Anaphylaxis is a severe, life-threatening, generalized or systemic hypersensitivity reaction characterized by rapid onset and compromised airway, breathing, or circulation. It is most commonly triggered in hospitalized patients by intravenous antibiotics (e.g., beta-lactams), radiocontrast media, blood products, neuromuscular blocking agents, chlorhexidine, latex, or certain foods.

Clinical Presentation: The ABC Approach

Anaphylaxis is diagnosed primarily on clinical grounds. Look for sudden onset (usually minutes to hours after trigger exposure) with rapid progression involving:

A (Airway Compromise): Pharyngeal or laryngeal oedema, tongue/lip swelling (angioedema), hoarse voice, difficulty swallowing, inspiratory stridor .

B (Breathing Compromise): Severe bronchospasm, audible expiratory wheeze , shortness of breath, chest tightness, tachypnoea, cyanosis, SpO 2 < 92 % \text{SpO}_2 <92\% SpO 2 ​ < 92% .

C (Circulation Compromise): Widespread vasodilation and increased capillary permeability leading to profound hypotension ( SBP < 90 mmHg \text{SBP} <90\text{ mmHg} SBP < 90 mmHg ), reflex tachycardia, weak thready pulse, clammy extremities, dizziness, syncope, and cardiovascular collapse.

Skin and Mucosal Changes: Occur in > 80 % >80\% > 80% of cases but may be absent in fulminant shock: generalized erythema, intense pruritus, urticaria (hives), and periorbital/facial angioedema.

Feature Anaphylaxis Vaso-Vagal Syncope (Faint)

Onset Rapid (minutes after exposure). Sudden, often preceded by emotional stress, pain, or prolonged standing.

Heart Rate Tachycardia (compensatory response to vasodilation). Bradycardia (vagal hyperstimulation).

Skin Erythema, warm flushing, urticaria, angioedema. Pale, cold, clammy, no rash or urticaria.

Airway / Lungs Stridor, hoarseness, bronchospasm, wheezing. Normal airway, no stridor, no wheezing.

Response to Supine Position Incomplete; hypotension persists due to distributive shock. Rapid spontaneous recovery of consciousness once supine.

Immediate First-Line Treatment: Intramuscular Adrenaline

Drug of Choice: Adrenaline (Epinephrine) 1:1,000 ( 1 mg/mL 1\text{ mg/mL} 1 mg/mL concentration).

Adult Dose: 0.5 mg 0.5\text{ mg} 0.5 mg ( 0.5 mL 0.5\text{ mL} 0.5 mL ) administered by Intramuscular (IM) injection.

Site of Administration: Anterolateral aspect of the middle third of the thigh (vastus lateralis) . The IM route in the thigh achieves significantly faster and higher peak plasma concentrations than subcutaneous administration or IM injection into the deltoid.

Repeat Dosing: If there is no clinical improvement in airway, breathing, or circulation, repeat the IM adrenaline dose after 5 minutes .

Mechanism: Alpha-1 receptor agonist activity reverses peripheral vasodilation and reduces mucosal/laryngeal oedema; Beta-1 activity increases myocardial contractility; Beta-2 activity relieves bronchospasm and inhibits further mast cell and basophil degranulation. [Suspected Anaphylaxis]

  • │
  • ┌───────────────┴───────────────┐
  • ▼ ▼
  • [Stop Trigger Immediately] [Call for Help / Dial 2222]
  • │ │
  • └───────────────┬───────────────┘
  • ▼
  • [First-Line Drug: Adrenaline 1:1,000 (0.5 mg IM) Vastus Lateralis]
  • │
  • ┌───────────────┴───────────────┐
  • ▼ ▼
  • [Position Correctly] [High-Flow Oxygen (15 L/min)]
  • Lie flat with legs elevated • Non-rebreather reservoir mask
  • (Sit up slightly if dyspnoea) • Target SpO2 94-98%
  • NEVER allow patient to stand!
  • │
  • ▼
  • [IV Fluid Resuscitation: Crystalloid 500-1000 mL bolus]
  • │
  • ▼

[Second-Line Adjuncts (Only AFTER Adrenaline)]:

  • IV Chlorphenamine 10 mg (slow IV / IM)
  • IV Hydrocortisone 200 mg (slow IV / IM)
  • Patient Positioning: Prevention of Caval Collapse

Position flat with legs elevated to optimize venous return to the heart.

If breathing difficulty or stridor is the predominant symptom, the patient may sit upright cautiously, but blood pressure must be monitored closely.

CRITICAL WARNING: Never permit an anaphylactic patient to stand up, walk, or sit up abruptly. Sudden changes to an upright posture cause catastrophic pooling of blood in dilated lower-extremity capacitance vessels, leading to the "empty vena cava syndrome," pulseless electrical activity (PEA), and instantaneous death within seconds.

Secondary Interventions & Monitoring

Intravenous Fluids: Rapid IV crystalloid bolus ( 500 – 1 , 000 mL 500\text{--}1,000\text{ mL} 500 – 1 , 000 mL Hartmann's or 0.9 % 0.9\% 0.9% Saline) for persistent hypotension.

Second-Line Drugs (Administer ONLY AFTER Adrenaline):

Antihistamine: Chlorphenamine 10 mg 10\text{ mg} 10 mg slow IV or IM (combats H1-mediated pruritus and urticaria).

Corticosteroid: Hydrocortisone 200 mg 200\text{ mg} 200 mg slow IV or IM (blunts late-phase inflammation and reduces risk of biphasic reactions ).

Observation Period: Monitor the patient for a minimum of 6 to 12 hours post-event, as biphasic anaphylaxis occurs in up to 20 % 20\% 20% of patients without renewed exposure to the allergen. Serial serum mast cell tryptase samples should be taken (immediately, at 1–2 hours, and > 24 hours >24\text{ hours} > 24 hours baseline).

2. Acute Hypoglycaemia: The "Rule of 15"

Hypoglycaemia is an acute metabolic emergency characterized by plasma glucose falling below physiological requirements. In Irish acute hospitals, clinical guidelines define hypoglycaemia as a capillary blood glucose < 4.0 mmol/L <4.0\text{ mmol/L} < 4.0 mmol/L ("Four is the Floor"), regardless of whether the patient exhibits overt symptoms.

Clinical Manifestations

Symptoms arise through two distinct pathophysiological mechanisms:

Autonomic (Neurogenic) Symptoms (Adrenaline release):

Diaphoresis (cold sweats), tremors/shakiness, tachycardia, palpitations, anxiety, pallor, hunger, pins and needles (paraesthesia).

Neuroglycopenic Symptoms (Direct cerebral glucose deprivation):

Confusion, drowsiness, slurred speech, behavioral changes, emotional lability, ataxia/unsteadiness, blurred vision, seizures, and eventual coma.

  • The "Rule of 15" Management Algorithm [Capillary Blood Glucose < 4.0 mmol/L]
  • │
  • ┌────────────────┴────────────────┐
  • ▼ ▼
  • [Patient Conscious & Able] [Patient Unconscious / Dysphagic / NPO]
  • [to Swallow Safely] │
  • │ ▼
  • ▼ [Position in Recovery Position]
  • [Step 1: Give 15-20g Fast Carb] • Maintain patent airway
  • 150-200 mL Fruit Juice/Soda • High-flow O2 if indicated
  • 4-5 Jelly Babies │
  • 3-4 Glucose Tablets ▼
  • 1 tube 40% Oral Glucose Gel [IV Access Present?]
  • │ │
  • ▼ ┌────────┴────────┐
  • [Step 2: Wait 15 Minutes &] ▼ ▼
  • [Recheck Blood Glucose] [YES] [NO]
  • │ │ │
  • ┌─────────┴─────────┐ ▼ ▼
  • ▼ ▼ [Give 100-150 mL [Give 1 mg IM Glucagon]
  • [Still < 4.0 mmol/L] [≥ 4.0 mmol/L] 10% Glucose IV] (Recheck BG in 10 min;
  • │ │ (over 10-15 min) secure IV access)]
  • ▼ ▼ │ │
  • [Repeat 15-20g [Step 3: Give └────────┬────────┘
  • Fast-acting Carb; Long-Acting Carb] │
  • Max 3 cycles] • Slice of toast ▼
  • 2 plain biscuits [Once BG ≥ 4.0 mmol/L & Alert]
  • Scheduled meal [Provide Long-Acting Complex Carb]

Detailed Treatment Pathways:

Stage 1: Conscious, Alert Patient (Oral Route Intact):

Administer 15 to 20 grams of quick-acting simple carbohydrate :

  • 150 – 200 mL 150\text{--}200\text{ mL} 150 – 200 mL pure fruit juice (orange or apple juice);
  • 4 to 5 jelly babies or fruit pastilles;
  • 3 to 4 glucose tablets;

1 tube of 40 % 40\% 40% oral glucose gel (e.g., Glucogel) massaged into buccal mucosa if cooperative but sluggish.

Wait 15 minutes and re-check capillary blood glucose.

If blood glucose is still < 4.0 mmol/L <4.0\text{ mmol/L} < 4.0 mmol/L , repeat the fast-acting carbohydrate (up to 3 cycles).

Once blood glucose is ≥ 4.0 mmol/L \ge 4.0\text{ mmol/L} ≥ 4.0 mmol/L , administer long-acting complex carbohydrate (e.g., a slice of bread/toast, 2 digestive biscuits, a glass of milk, or the patient's next scheduled meal) to prevent recurrent hypoglycaemia as circulating insulin continues to act.

Stage 2: Unconscious, Confused, Dysphagic, or Nil-by-Mouth Patient:

Danger: Never attempt to administer fluids or solids orally to a drowsy or unconscious patient due to the catastrophic risk of aspiration.

Place patient in the lateral recovery position and summon the medical team (dial 2222 if unrousable or fitting).

If IV Access is available: Administer 100 to 150 mL 100\text{ to }150\text{ mL} 100 to 150 mL of 10 % 10\% 10% Glucose (Dextrose) intravenously over 10–15 minutes. Alternatively, administer 50 mL 50\text{ mL} 50 mL of 20 % 20\% 20% Glucose. Note: Avoid hypertonic 50 % 50\% 50% glucose if possible due to extreme hyperosmolarity, severe thrombophlebitis, and tissue necrosis if extravasation occurs.

If NO IV Access is available: Administer Glucagon 1 mg 1\text{ mg} 1 mg by Intramuscular (IM) or Subcutaneous (SC) injection.

Glucagon acts by mobilizing glycogen stores from the liver. It may take 10–15 minutes to raise blood glucose and is ineffective in patients with depleted glycogen stores (e.g., severe malnutrition, prolonged fasting, end-stage liver disease, or chronic alcohol misuse).

When the patient regains consciousness and can swallow safely, give oral complex carbohydrates immediately.

3. Acute Seizure Management & Status Epilepticus

An epileptic seizure is a transient occurrence of signs and symptoms resulting from abnormal excessive or synchronous neuronal activity in the brain. In general medical wards, seizures may stem from epilepsy, acute stroke, intracranial hemorrhage, alcohol withdrawal, electrolyte derangements (severe hyponatraemia, hypocalcaemia), meningitis, or drug toxicity.

Acute Seizure First-Aid: Protecting the Patient from Harm

When witnessing an acute convulsive (generalized tonic-clonic) seizure, the nurse's immediate priority is preservation of safety and airway:

Note the Time: Look at the clock immediately. Accurately timing the onset and duration of the seizure is critical for emergency drug escalation.

Prevent Physical Injury:

Guide the patient gently away from hazards (radiators, sharp furniture edges).

Cushion the patient's head using a soft pillow, folded blanket, or clothing.

Ensure padded bed rails are elevated if the patient is in bed.

Loosen tight clothing around the neck (ties, tight collars).

What NOT to Do (Universal Nursing Rules):

DO NOT restrain the patient: Restraining limbs during the tonic-clonic phase causes musculoskeletal tears, fractures, or joint dislocations.

DO NOT place anything in the patient's mouth: Never insert tongue depressors, airway adjuncts, spoons, or fingers. This can fracture teeth, trigger laryngospasm, and cause complete airway occlusion.

DO NOT attempt oral medication or fluids.

Maintain Oxygenation: Administer high-flow oxygen via a non-rebreather mask held near the face if the convulsive phase permits.

Post-Ictal Positioning: As soon as active clonic jerking stops, place the patient into the lateral recovery position to allow oral secretions and vomit to drain freely, preventing aspiration, and perform gentle suctioning if required.

Status Epilepticus Protocol

Definition: A continuous convulsive seizure lasting ≥ 5 minutes \ge 5\text{ minutes} ≥ 5 minutes , or two or more sequential seizures without full recovery of consciousness between episodes.

Pathophysiological Risk: Prolonged convulsive activity leads to hyperpyrexia, systemic lactic acidosis, rhabdomyolysis, respiratory compromise, neuronal necrosis, and permanent neurological deficit. It is a critical medical emergency requiring 2222 escalation.

Stage & Timeframe Clinical Condition Pharmacological Intervention & Protocol

Stage 1 (0–5 min) Early seizure activity Ensure patient safety, maintain airway, administer high-flow oxygen, check capillary blood glucose immediately to exclude hypoglycaemia.

Stage 2 (5–10 min) Established Status Epilepticus ( > 5 min >5\text{ min} > 5 min ) Administer first-line emergency benzodiazepine:; • IV Access Present: IV Lorazepam 4 mg 4\text{ mg} 4 mg (slow bolus over 2 minutes; 0.1 mg/kg 0.1\text{ mg/kg} 0.1 mg/kg ) or IV Diazepam 10 mg 10\text{ mg} 10 mg .; • No IV Access: Buccal Midazolam 10 mg 10\text{ mg} 10 mg (instill into buccal cavity between lower gum and cheek) or Rectal Diazepam 10 mg 10\text{ mg} 10 mg .

Stage 3 (10–25 min) Refractory Status Epilepticus (seizure persists 5–10 min after 1st dose) Repeat benzodiazepine once if ordered, or proceed directly to second-line IV anti-epileptic infusions under medical/ICU direction:; • IV Levetiracetam ( 60 mg/kg 60\text{ mg/kg} 60 mg/kg , max 4 , 500 mg 4,500\text{ mg} 4 , 500 mg ); OR; • IV Sodium Valproate ( 40 mg/kg 40\text{ mg/kg} 40 mg/kg , max 3 , 000 mg 3,000\text{ mg} 3 , 000 mg ); OR; • IV Phenytoin ( 20 mg/kg 20\text{ mg/kg} 20 mg/kg infusion with ECG monitoring).

Stage 4 (>30–60 min) Super-refractory Status Epilepticus Urgent transfer to Intensive Care Unit (ICU) for general anaesthesia (Propofol, Midazolam, or Thiopentone infusion) and continuous electroencephalogram (EEG) monitoring.

4. Practical OSCE Guidance for NMBI Candidates

In the RCSI Overseas Aptitude Test OSCE, acute emergency stations frequently evaluate anaphylaxis, hypoglycaemic collapse, or seizure management:

Adrenaline Dose Verbalization: Never hesitate when asked for the anaphylaxis dose. State clearly: "Adrenaline 1:1,000, 0.5 mg, which is 0.5 mL, intramuscularly into the anterolateral aspect of the middle third of the thigh."

Hypoglycaemia Verification: Always check capillary blood glucose before administering emergency medications to an altered patient. Remember the rule: "Four is the floor—treat below 4.0 mmol/L with 15 to 20 grams of fast-acting sugar, wait 15 minutes, recheck."

Seizure Timing: During a simulated seizure station, look visibly at your watch or the wall clock and state: "I am noting the time of onset. The seizure has lasted 3 minutes; I am preparing emergency buccal midazolam or IV lorazepam if it reaches 5 minutes."

Post-Event Assessment: Always document post-event vital signs, neurological status (GCS/ACVPU), pupil size and reactivity, blood glucose, and any injury sustained.